NASDAQ:CLXT - Calyxt Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$17.09 +0.12 (+0.71 %)
(As of 05/27/2018 04:00 PM ET)
Previous Close$17.09
Today's Range$16.80 - $18.49
52-Week Range$9.26 - $31.89
Volume169,487 shs
Average Volume142,439 shs
Market Capitalization$478.88 million
P/E Ratio-15.26
Dividend YieldN/A
BetaN/A

About Calyxt (NASDAQ:CLXT)

Calyxt logoCalyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in New Brighton, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Debt-to-Equity Ratio0.27
Current Ratio17.79
Quick Ratio17.79

Price-To-Earnings

Trailing P/E Ratio-15.26
Forward P/E Ratio-14.24
P/E GrowthN/A

Sales & Book Value

Annual Sales$510,000.00
Price / Sales938.94
Cash FlowN/A
Price / CashN/A
Book Value$1.92 per share
Price / Book8.90

Profitability

EPS (Most Recent Fiscal Year)($1.12)
Net Income$-25,980,000.00
Net Margins-5,930.60%
Return on Equity-60.81%
Return on Assets-46.54%

Miscellaneous

Employees35
Outstanding Shares28,020,000

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How were Calyxt's earnings last quarter?

Calyxt (NASDAQ:CLXT) issued its earnings results on Monday, May, 7th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.13. The business earned $0.01 million during the quarter, compared to the consensus estimate of $0.20 million. Calyxt had a negative return on equity of 60.81% and a negative net margin of 5,930.60%. View Calyxt's Earnings History.

What price target have analysts set for CLXT?

5 equities research analysts have issued 12-month target prices for Calyxt's shares. Their predictions range from $22.00 to $34.25. On average, they anticipate Calyxt's share price to reach $29.05 in the next year. View Analyst Ratings for Calyxt.

What are Wall Street analysts saying about Calyxt stock?

Here are some recent quotes from research analysts about Calyxt stock:
  • 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (3/23/2018)
  • 2. Jefferies Group LLC analysts commented, "CLXT’s 1st product launch, HOSO, is tracking better than expected & its high- fiber wheat product (significantly more profitable than HOSO) just received non-regulated status. In addition, recent developments around gene-editing on the global regulatory front have been positive and point to a potentially larger TAM. We continue to believe the market is underestimating the value of CLXT’s R&D pipeline and, as such, we reiterate our Buy rating & $27 PT. We remain encouraged by commentary on the HOSO commercialization progress. Mgmt’s HOSO commercialization plan continues to track in line with or better than our previous expectations. We were previously assuming ~50 contracted farmers in 2018, however the company has already contracted with “over 60” farmers thus far, representing ~$11.5K acres of CLXT’s HO soybeans (we were assuming $10K acres in 2018). In addition, farmer retention rates have been very strong (>90%) & repeat growers, on average, are planting >2x their previous acres of CLXT’s HO variety, which bodes well for a successful commercialization. The company remains engaged with about a dozen small to large food company customers on HOSO." (3/22/2018)

Who are some of Calyxt's key competitors?

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:
  • Mr. Federico A. Tripodi, Chief Exec. Officer (Age 41)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 55)
  • Mr. Bryan W. J. Corkal, CFO and Principal Financial & Accounting Officer (Age 50)
  • Simon Harnest, VP of Fin. & Investor Relations
  • Ms. Jennifer Moore, VP of Communications

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Has Calyxt been receiving favorable news coverage?

Media stories about CLXT stock have been trending somewhat positive recently, according to Accern. The research firm rates the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Calyxt earned a daily sentiment score of 0.10 on Accern's scale. They also assigned news articles about the company an impact score of 46.63 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.15%), Northern Trust Corp (0.20%) and Wells Fargo & Company MN (0.14%). Company insiders that own Calyxt stock include Alain Godard, Bryan WJ Corkal, Daniel F Voytas, Manoj Sahoo, Michel Arbadji and Philippe Dumont. View Institutional Ownership Trends for Calyxt.

Which major investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. and Northern Trust Corp. Company insiders that have sold Calyxt company stock in the last year include Alain Godard, Bryan WJ Corkal, Daniel F Voytas, Manoj Sahoo and Michel Arbadji. View Insider Buying and Selling for Calyxt.

Which major investors are buying Calyxt stock?

CLXT stock was purchased by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN. View Insider Buying and Selling for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $17.09.

How big of a company is Calyxt?

Calyxt has a market capitalization of $478.88 million and generates $510,000.00 in revenue each year. The company earns $-25,980,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Calyxt employs 35 workers across the globe.

How can I contact Calyxt?

Calyxt's mailing address is 600 COUNTY ROAD D WEST SUITE 8, NEW BRIGHTON MN, 55112. The company can be reached via phone at 651-683-2807 or via email at [email protected]


MarketBeat Community Rating for Calyxt (CLXT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  197
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Calyxt (NASDAQ:CLXT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Calyxt in the last 12 months. Their average twelve-month price target is $29.05, suggesting that the stock has a possible upside of 69.98%. The high price target for CLXT is $34.25 and the low price target for CLXT is $22.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.802.802.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $29.05$29.05$29.05$27.75
Price Target Upside: 69.98% upside65.62% upside37.55% upside54.68% upside

Calyxt (NASDAQ:CLXT) Consensus Price Target History

Price Target History for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ:CLXT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/22/2018Jefferies GroupReiterated RatingBuy$27.00MediumView Rating Details
12/20/2017Ladenburg ThalmannInitiated CoverageBuy ➝ Buy$34.25HighView Rating Details
11/16/2017CitigroupLower Price TargetNeutral$27.00 ➝ $22.00N/AView Rating Details
10/30/2017BMO Capital MarketsInitiated CoverageOutperform$32.00N/AView Rating Details
9/29/2017Wells Fargo & CoBoost Price TargetOutperform$17.00 ➝ $30.00MediumView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Calyxt (NASDAQ:CLXT) Earnings History and Estimates Chart

Earnings by Quarter for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ:CLXT) Earnings Estimates

2018 EPS Consensus Estimate: ($1.21)
2019 EPS Consensus Estimate: ($1.12)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.31)($0.31)($0.31)
Q2 20181($0.28)($0.28)($0.28)
Q3 20181($0.30)($0.30)($0.30)
Q4 20181($0.32)($0.32)($0.32)
Q1 20191($0.22)($0.22)($0.22)
Q2 20191($0.27)($0.27)($0.27)
Q3 20191($0.30)($0.30)($0.30)
Q4 20191($0.33)($0.33)($0.33)
Q1 20201($0.15)($0.15)($0.15)

Calyxt (NASDAQ CLXT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018Q1($0.2880)($0.16)$0.20 million$0.01 millionViewN/AView Earnings Details
3/13/2018Q4 2017($0.21)($0.24)$0.10 million$0.19 millionViewN/AView Earnings Details
11/13/2017Q3 2017($0.16)($0.51)$0.10 million$0.04 millionViewN/AView Earnings Details
9/1/2017Q2 2017($0.11)($0.17)$0.22 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Calyxt (NASDAQ:CLXT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Calyxt (NASDAQ CLXT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.80%
Institutional Ownership Percentage: 21.78%
Insider Trading History for Calyxt (NASDAQ:CLXT)
Institutional Ownership by Quarter for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ CLXT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/21/2018Daniel F. VoytasInsiderSell4,666$16.63$77,595.58View SEC Filing  
5/8/2018Daniel F. VoytasInsiderSell4,083$15.58$63,613.14View SEC Filing  
4/20/2018Daniel F. VoytasInsiderSell4,666$16.87$78,715.42View SEC Filing  
4/9/2018Daniel F. VoytasInsiderSell4,083$14.38$58,713.54View SEC Filing  
3/20/2018Daniel F VoytasInsiderSell4,666$17.91$83,568.064,666View SEC Filing  
3/12/2018Alain GodardDirectorSell10,000$19.00$190,000.0049,200View SEC Filing  
3/9/2018Alain GodardDirectorSell10,000$19.00$190,000.0049,200View SEC Filing  
3/5/2018Alain GodardDirectorSell10,000$19.00$190,000.0049,200View SEC Filing  
2/28/2018Michel ArbadjiDirectorSell3,500$18.63$65,205.0032,900View SEC Filing  
2/26/2018Alain GodardDirectorSell10,000$19.03$190,300.00View SEC Filing  
2/22/2018Alain GodardDirectorSell19,825$19.65$389,561.2545,325View SEC Filing  
2/21/2018Manoj SahooInsiderSell10,780$19.87$214,198.6095,146View SEC Filing  
2/20/2018Alain GodardDirectorSell6,125$20.70$126,787.5045,325View SEC Filing  
2/20/2018Bryan W.J. CorkalCFOSell19,600$20.73$406,308.0092,300View SEC Filing  
7/25/2017Philippe DumontDirectorBuy400$8.00$3,200.0019,600View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Calyxt (NASDAQ CLXT) News Headlines

Source:
DateHeadline
Calyxt (CLXT) Insider Sells $77,595.58 in StockCalyxt (CLXT) Insider Sells $77,595.58 in Stock
www.americanbankingnews.com - May 23 at 4:33 PM
Cellectis S.A. : Calyxt Announces Successful Closing of $60.9 Million Public OfferingCellectis S.A. : Calyxt Announces Successful Closing of $60.9 Million Public Offering
www.streetinsider.com - May 23 at 9:12 AM
Calyxt Announces Successful Closing of $60.9 Million Public OfferingCalyxt Announces Successful Closing of $60.9 Million Public Offering
finance.yahoo.com - May 22 at 4:24 PM
Cellectis S.A.: Calyxt Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesCellectis S.A.: Calyxt Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
www.bizjournals.com - May 21 at 4:25 PM
Cellectis S.A.: Calyxt Announces Full Exercise of Underwriters Option to Purchase Additional SharesCellectis S.A.: Calyxt Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
www.finanznachrichten.de - May 21 at 9:17 AM
Head-To-Head Comparison: Calyxt (CLXT) & CF Industries (CF)Head-To-Head Comparison: Calyxt (CLXT) & CF Industries (CF)
www.americanbankingnews.com - May 20 at 11:16 PM
Calyxt (CLXT) Receives Average Rating of "Hold" from BrokeragesCalyxt (CLXT) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 19 at 1:35 AM
Calyxt prices upsized stock offering at $15Calyxt prices upsized stock offering at $15
seekingalpha.com - May 18 at 10:24 AM
Calyxt down 6% on launching follow-on offeringCalyxt down 6% on launching follow-on offering
seekingalpha.com - May 16 at 9:45 AM
Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery CourtBayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court
finance.yahoo.com - May 15 at 4:46 PM
Financial Survey: Monsanto (MON) and Calyxt (CLXT)Financial Survey: Monsanto (MON) and Calyxt (CLXT)
www.americanbankingnews.com - May 14 at 9:12 PM
Comparing The Mosaic (MOS) & Calyxt (CLXT)Comparing The Mosaic (MOS) & Calyxt (CLXT)
www.americanbankingnews.com - May 14 at 3:11 AM
Calyxts (CLXT) CEO Federico Tripodi on Q1 2018 Results - Earnings Call TranscriptCalyxt's (CLXT) CEO Federico Tripodi on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 10:10 AM
Calyxt to Post Q2 2018 Earnings of ($0.28) Per Share, Jefferies Group Forecasts (CLXT)Calyxt to Post Q2 2018 Earnings of ($0.28) Per Share, Jefferies Group Forecasts (CLXT)
www.americanbankingnews.com - May 11 at 9:05 AM
Insider Selling: Calyxt (CLXT) Insider Sells 4,083 Shares of StockInsider Selling: Calyxt (CLXT) Insider Sells 4,083 Shares of Stock
www.americanbankingnews.com - May 10 at 8:21 PM
Calyxt (CLXT) Announces Quarterly  Earnings ResultsCalyxt (CLXT) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 8 at 9:52 AM
Calyxt beats by $0.13, misses on revenueCalyxt beats by $0.13, misses on revenue
seekingalpha.com - May 8 at 9:25 AM
Calyxt: 1Q Earnings SnapshotCalyxt: 1Q Earnings Snapshot
finance.yahoo.com - May 8 at 9:25 AM
Calyxt Reports Financial Results for First Quarter 2018Calyxt Reports Financial Results for First Quarter 2018
finance.yahoo.com - May 7 at 4:36 PM
Calyxt (CLXT) versus CVR Partners (UAN) Head-To-Head SurveyCalyxt (CLXT) versus CVR Partners (UAN) Head-To-Head Survey
www.americanbankingnews.com - May 7 at 11:24 AM
Financial Comparison: Calyxt (CLXT) and Scotts Miracle-Gro (SMG)Financial Comparison: Calyxt (CLXT) and Scotts Miracle-Gro (SMG)
www.americanbankingnews.com - May 6 at 8:13 PM
Calyxt (CLXT) versus Its Peers Head-To-Head SurveyCalyxt (CLXT) versus Its Peers Head-To-Head Survey
www.americanbankingnews.com - April 29 at 3:15 PM
Contrasting Calyxt (CLXT) and Its PeersContrasting Calyxt (CLXT) and Its Peers
www.americanbankingnews.com - April 28 at 3:18 PM
Calyxt (CLXT) vs. The Competition Critical SurveyCalyxt (CLXT) vs. The Competition Critical Survey
www.americanbankingnews.com - April 28 at 7:37 AM
Calyxt to Hold First Quarter 2018 Investor Conference Call on Tuesday, May 8, at 8 a.m. EDT – 7 a.m. CDTCalyxt to Hold First Quarter 2018 Investor Conference Call on Tuesday, May 8, at 8 a.m. EDT – 7 a.m. CDT
finance.yahoo.com - April 26 at 9:17 AM
Calyxt (CLXT) Insider Daniel F. Voytas Sells 4,666 SharesCalyxt (CLXT) Insider Daniel F. Voytas Sells 4,666 Shares
www.americanbankingnews.com - April 24 at 7:50 PM
Calyxt (CLXT) Receives Consensus Rating of "Hold" from AnalystsCalyxt (CLXT) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 24 at 1:30 AM
Analyzing Calyxt (CLXT) and Its CompetitorsAnalyzing Calyxt (CLXT) and Its Competitors
www.americanbankingnews.com - April 23 at 7:18 PM
Calyxt (CLXT) versus The Competition Financial AnalysisCalyxt (CLXT) versus The Competition Financial Analysis
www.americanbankingnews.com - April 22 at 1:22 AM
Comparing Calyxt (CLXT) & Scotts Miracle-Gro (SMG)Comparing Calyxt (CLXT) & Scotts Miracle-Gro (SMG)
www.americanbankingnews.com - April 20 at 5:24 PM
Calyxt (CLXT) & Its Competitors Head to Head ComparisonCalyxt (CLXT) & Its Competitors Head to Head Comparison
www.americanbankingnews.com - April 20 at 1:26 AM
Calyxt (CLXT) & Its Rivals Financial ComparisonCalyxt (CLXT) & Its Rivals Financial Comparison
www.americanbankingnews.com - April 19 at 11:14 PM
Research Analysts Set Expectations for Calyxts Q3 2018 Earnings (CLXT)Research Analysts Set Expectations for Calyxt's Q3 2018 Earnings (CLXT)
www.americanbankingnews.com - April 19 at 6:36 AM
Critical Contrast: Calyxt (CLXT) vs. Its RivalsCritical Contrast: Calyxt (CLXT) vs. Its Rivals
www.americanbankingnews.com - April 17 at 11:10 PM
Financial Contrast: Calyxt (CLXT) and Its RivalsFinancial Contrast: Calyxt (CLXT) and Its Rivals
www.americanbankingnews.com - April 17 at 7:13 PM
Financial Analysis: Calyxt (CLXT) vs. Its CompetitorsFinancial Analysis: Calyxt (CLXT) vs. Its Competitors
www.americanbankingnews.com - April 14 at 1:02 PM
Calyxt (CLXT) and Its Peers Head-To-Head SurveyCalyxt (CLXT) and Its Peers Head-To-Head Survey
www.americanbankingnews.com - April 14 at 1:11 AM
Calyxt (CLXT) Insider Sells $58,713.54 in StockCalyxt (CLXT) Insider Sells $58,713.54 in Stock
www.americanbankingnews.com - April 11 at 10:37 PM
Calyxt (CLXT) Research Coverage Started at Wells FargoCalyxt (CLXT) Research Coverage Started at Wells Fargo
www.americanbankingnews.com - April 10 at 5:34 PM
Comparing Calyxt (CLXT) and Its CompetitorsComparing Calyxt (CLXT) and Its Competitors
www.americanbankingnews.com - April 7 at 12:01 PM
Calyxt Exceeds Farmer Adoption Milestone for High-Oleic Soybean Product LaunchCalyxt Exceeds Farmer Adoption Milestone for High-Oleic Soybean Product Launch
finance.yahoo.com - April 6 at 9:57 AM
Calyxt (CLXT) Receives New Coverage from Analysts at BMO Capital MarketsCalyxt (CLXT) Receives New Coverage from Analysts at BMO Capital Markets
www.americanbankingnews.com - April 4 at 2:58 PM
Calyxt (CLXT) and Its Competitors Head-To-Head ContrastCalyxt (CLXT) and Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - April 3 at 1:18 AM
Reviewing Calyxt (CLXT) and Its RivalsReviewing Calyxt (CLXT) and Its Rivals
www.americanbankingnews.com - April 2 at 1:30 AM
Calyxt (CLXT) versus Its Peers Head to Head ReviewCalyxt (CLXT) versus Its Peers Head to Head Review
www.americanbankingnews.com - March 31 at 5:10 PM
Calyxt (CLXT) Given Consensus Rating of "Hold" by AnalystsCalyxt (CLXT) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - March 30 at 1:32 AM
Calyxt (CLXT) Expected to Earn Q1 2018 Earnings of ($0.31) Per ShareCalyxt (CLXT) Expected to Earn Q1 2018 Earnings of ($0.31) Per Share
www.americanbankingnews.com - March 26 at 1:06 AM
Jefferies Group Reiterates Buy Rating for Calyxt (CLXT)Jefferies Group Reiterates Buy Rating for Calyxt (CLXT)
www.americanbankingnews.com - March 23 at 9:34 PM
Calyxt (CLXT) Downgraded by Zacks Investment ResearchCalyxt (CLXT) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 23 at 8:28 PM
Calyxt Forecasted to Post FY2022 Earnings of ($0.14) Per Share (CLXT)Calyxt Forecasted to Post FY2022 Earnings of ($0.14) Per Share (CLXT)
www.americanbankingnews.com - March 23 at 5:19 PM

SEC Filings

Calyxt (NASDAQ:CLXT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Calyxt (NASDAQ:CLXT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Calyxt (NASDAQ CLXT) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.